Diabetes, often referred to by doctors as diabetes mellitus (DM), describes a group of metabolic diseases in which the person has high blood sugar levels (high blood glucose or blood sugar) over a prolonged period. The pancreas either produces little or no insulin (Type 1 DM) or the cells of the body do not respond properly to the insulin produced (Type 2 DM). Without insulin the glucose remains in the bloodstream and the blood glucose level rises. This causes health problems related to diabetes, such as cardiovascular diseases, chronic kidney disease, damage to the eyes (diabetic retinopathy), damage to the nerves of the body (diabetic neuropathy) etc. Insulin infusion plays a primary role in the management of diabetes mellitus as well as monitoring the glucose levels in the blood.
The infusion of insulin can be achieved either by Insulin pens or Continuous Subcutaneous Insulin Infusion Pumps (CSII) which deliver a constant supply of insulin. Continuous Glucose Monitoring devises (CGMs devices) can be used for the monitoring of the glucose levels in the blood.
The Continuous Subcutaneous Insulin Infusion Pump (CSII) is a technologically advanced device which accurately administers insulin subcutaneously at a constant low level, in order to restore the normal insulin secretion in the body.
The CGMs devices can measure the glucose levels in the body every 5 minutes and provide reports of the patient’s full clinical picture to the patient and the doctor in order to best manage diabetes.
Articles sources: 01. www.medtronic.gr
area of activity
DIABETES MANAGEMENT PRODUCTS
Attica - Peloponnese - Western Greece
Crete - Dodecanese islands
Eastern Aegean islands - Cyclades islands